Table 10.
Application of HEC in ocular drug delivery.
| Cellulosic Polymer | Drug Used | Application of Polymer | Effect on Drug Property | Ref |
|---|---|---|---|---|
| HEC | Dorzolamide | Sustained release, decrease dosing frequency | Reduction in IOP for 2 week an drug also showed neuroprotective effect | [68] |
| Ketorolac tromethamine | Effective carrier for delivery of the drug | Enhanced EE% and drug loading was 45.4 and 36.3% | [224] | |
| Azithromycin | Sustained release and improve ocular performance | Enhanced EE% up to 62.167 ± 0.07% and prolonged drug release for 121 h | [225] | |
| Betaxolol | Prolongation of pre-corneal retention and enhanced relative bioavailability | Enhanced encapsulation efficiency (69 ± 5%) and relative bioavailability (280 and 254.7%) | [226] | |
| Phenylephrine and tropicamide | Extended-release | Enhanced force of bioadhesion (5688 mpa) and mucoadhesive property 172.75 ± 50.81 pa and enhanced bioavailability | [227] | |
| Povidone-iodine | Additive effect for feline herpesvirus type1 and C Felis. | Enhanced relative cell viability up to 52.7 ± 2.1% v/v and significantly reduced C. felis growth | [228] | |
| Cysteamine | Viscosity enhancer | Enhanced drug released for 45–50 min, and combined with bioadhesive nature of gel results in enhanced bioavailability | [229] | |
| Oxidized hydroxy ethyl cellulose | Safe development, fashionable, and PH detectable contact lenses | Non-cytotoxic with excellent photochromic property of 2 × 10−4 and transparency up to 93% with compression strength 8.5 MPa | [63] |